Recent clinical data surrounding the medication Retatrutide , specifically the 120 milligram formulation branded as ZPHC, indicate a impressive effect on weight decrease and associated health factors. Researchers posit that this dual acting , targeting both GLP-1 and GIP receptors , has the poten